Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 1, 2016, Pages 273-276

  Göhler, Stella ^a   Da Silva Filho, Miguel Inacio ^a   Johansson, Robert ^b   Enquist Olsson, Kerstin ^b   Henriksson, Roger ^b,c   Hemminki, Kari ^a,d   Lenner, Per ^b   Försti, Asta ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UMEÅ UNIVERSITY   (Sweden)

^c Regional Cancer Center Stockholm and Gotland   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

APOBEC3; Breast cancer; Deletion polymorphism; Germline variants; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; ESTROGEN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; APOBEC3A PROTEIN, HUMAN; APOBEC3B PROTEIN, HUMAN; CYTIDINE DEAMINASE; PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GENE DELETION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GERMLINE MUTATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST NEOPLASMS; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENETICS; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; SWEDEN;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTIDINE DEAMINASE; FEMALE; FOLLOW-UP STUDIES; GERM-LINE MUTATION; HUMANS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEINS; SEQUENCE DELETION; SURVIVAL RATE; SWEDEN;

EID: 84953638836     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-2038-7     Document Type: Article

References (7)

1. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B et al (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494(7437):366–370. doi:10.1038/nature11881
2. Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE (2007) Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 3(4):e63. doi:10.1371/journal.pgen.0030063
3. Long J, Delahanty RJ, Li G, Gao YT, Lu W, Cai Q et al (2013) A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst 105(8):573–579. doi:10.1093/jnci/djt018
4. Sieuwerts AM, Willis S, Burns MB, Look MP, Meijer-Van Gelder ME, Schlicker A et al (2014) Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers. Horm Cancer 5(6):405–413. doi:10.1007/s12672-014-0196-8
5. Smith HC, Bennett RP, Kizilyer A, McDougall WM, Prohaska KM (2012) Functions and regulation of the APOBEC family of proteins. Semin Cell Dev Biol 23(3):258–268. doi:10.1016/j.semcdb.2011.10.004
6. Varadi V, Brendle A, Brandt A, Johansson R, Enquist K, Henriksson R et al (2009) Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer 45(17):3008–3016. doi:10.1016/j.ejca.2009.08.012
7. Xuan D, Li G, Cai Q, Deming-Halverson S, Shrubsole MJ, Shu XO et al (2013) APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 34(10):2240–2243. doi:10.1093/carcin/bgt185